Antibiogram of Klebsiella pneumoniae isolates from Buea, Cameroon

Central African Journal of Medicine

Volumn 47, Issue 7, 2001, Pages 173-176

  Ndip, R N ^a,c   Titanji, V P K ^a   Akenji, T N ^a   Mutanga, A M ^a   Mbacham, W F ^b   Ndip, L M ^a  

^a Universities of Buea   (Cameroon)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c UNIVERSITY OF BUEA   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAMEROON; CROSS INFECTION; DRUG EFFECT; ENTEROBACTER INFECTION; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PROSPECTIVE STUDY;

CAMEROON; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES;

EID: 0035401146     PISSN: 00089176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ardanuy C, Linares J, Dominguez MA, Hernandesalles S, Benedi VJ, Martinez-Martinez L. Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. Antimicrob Agent Chemother 1998;42:636-40.
2. Pena C, Pujol M, Ardanuy C, Ricart A, Pallares R, Linares J, et al. An outbreak of hospital-acquired Klebsiella pneumoniae bacteremia, including strains producing extended-spectrum β-lactamase. J Hosp Infect 2001;47:53-9.
3. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992;24:19-24.
4. Livrelli V, De Champs C, Di Martino P, Darfeuille-Michaud A, Forestier C, Joly B. Adhesive properties and antibiotic resistance of Klebsiella, Enterobacter, and Serratia clinical isolates involved in nosocomial infections. J Clin Microbiol 1996;34:1963-9.
5. Brun-Buisson C, Legrand P, Phillipon A. Montravers F, Ansquer M, Duvai J. Transferable antibiotic resistance to third generation cephalosporins during nosocomial outbreaks of multi-resistant K. pneumoniae. Lancet 1987;2:302-6.
6. Bauernfeind A, Rosenthal E, Eberlein E, Holley M, Schweighart S. Spread of Klebsiella pneumoniae producing SHV-5 β-lactamase among hospitalised patients. Infect 1993;21:18-22.
7. Pena C, Pujol M, Ardanuy C, Ricart A, Pallares R, Linares J, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pnuemoniae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998;42:53-8.
8. Szabo D, Filetoth Z, Szentandrassy J, Nemedi M, Toth E, Jeney C, et al. Molecular epidemiology of a cluster of cases due to Klebsiella pneumoniae producing SHV-5 extended-spectrum β-lactamase in the premature intensive care unit of a Hungarian hospital. J Clin Microbiol 1999;37:4167-9.
9. Seal DV, McSwiggan DA, Datta N, Feltham RKA. Characterisation of an epidemic strain of Klebsiella and its variants by computer analysis. J Med Microbiol 1991;14:295-305.
10. Eisen D, Russell EG, Tymms M, Roper EJ, Grayson ML, Turnidge J. Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multiresistant Klebsiella pneumoniae. J Clin Microbiol 1995;33:713-17.
11. Gori A, Espinasse F, Delplano A, Nonhoff C, Nicolas MH, Strulens MJC. Comparison of PFGE and RAPD for typing ESBL producing K. pneumoniae. J Clin Microbiol 1996;34(10):2448-53.
12. Fulthrope RR, Lis SN, Allen DG. Characterisation of bacteria isolates from a bleached Kraft pulp mill waste water treatment system. J Med Microbiol 1996;42(4):282-90.
13. Ammah A, Akenji TN, Ndip R, Deas J. An update on concurrent malaria and typhoid fever in Cameroon. Trans R Soc Trop Med Hyg 1999;93:127-9.
14. Sirot J, Chanal C, Petit A, Sirot D, Labia R, Gerbaud G. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated β-lactamases markedly active against third generation cephalosporins: epidemiologic studies. Rev Infect Dis 1988;10:850-9.
15. Abimbola KA, Obi CL, Alabi SA, Olukoya DK, Ndip RN. Current status on biotyping, antibiogram and plasmid profiles of E. coli isolates. E Afr Med J 1993;70(4):201-10.
16. Pai H, Lyu S, Lee JH, Kim J, Kwon Y, Kim J-W, et al. Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J Clin Microbiol 1999;37:1758-63.
17. Hogg GC, Forsyth JRL, Hibberd J, McBride J. Importance of resistant Klebsiella species in Victoria. Med J Aust 1993;158:772.
18. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128-40.
19. Cheesbrough M. Enteric Gram-negative rods and Gram-negative anaerobes; genus Klebsiella. In: Medical laboratory manual for tropical countries. ELBS, editors. Oxford:Butterworth-Heineman, 1991:262-4.
20. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. National Committee for Clinical Laboratory Standards 1997, Wayne, Pa.
21. Bauer AW, Kirby MM, Sharis JL, Turck M. Antibiotic susceptibility testing by a standard single disk method. Am J Clin Pathol 1966;45:493-6.
22. Pitout JDD, Thomson KS, Hanson ND, Ehrhardt AF, Moland ES, Sanders CC. β- lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother 1998;42:1350-4.
23. Prodinger WM, Fille M, Bauernnfeind A, Stemplanger I, Amann S, Pfausler B, et al. Molecular epidemiology of K. Pneumoniae producing SHV-5 b-lactamase. Parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol 1996;34(3):564-8.
24. Shanon K, Stapleton P, Xiang X, Johnson A, Beattie H, Bakri FE, et al. Extended-spectrum b-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom. J Clin Microbiol 1998;36:3105-10.
25. Tenovar FC, Mohammed MJ, Stelling J, O'Brien T, Williams R. Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organisation's external quality assurance system for antimicrobial susceptibility testing. J Clin Microbiol 2001;39:241-50.
26. Sanders CC, Sander Jnr, WE. b-lactamase resistance in Gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992;15:824-39.
27. Hassen BA, Fournier G, Kechrid A, Fendri C, Redjeb SB, Philippon A. Resistance enzymatique au cefotaxime chez cinquante six souches de Klebsiella spp. Escherichia coli et Salmonella spp. dans un hospital Tunisien (1984-1988). Pathol Biol 1990;38:464-9.
28. Moland ES, Sanders CC, Thomson KS. Can results obtained with commercially available microscan microdilution panels serve as an indicator of b-lactamase production among Escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam? J Clin Microbiol 1998;36:2575-9.
29. th ed. Durthen, North Carolina, USA: 1992:358-449.
30. Navaratnam P, Jamuna V, Hany A, Lakshmy I, Selvi P, Anusha A. Epidemiology and molecular characterization of nosocomially transmitted multidrug-resistant K. pneumoniae. Int J Infect Dis 2000;4:123-8.